Compile Data Set for Download or QSAR
Report error Found 397 Enz. Inhib. hit(s) with all data for entry = 12165
TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683511(US20240217978, Example 166 | (2S)-2-((7-amino-2-(f...)
Affinity DataIC50: 0.0800nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683495(US20240217978, Example 150 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 0.100nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683514(US20240217978, Example 169 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 0.100nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683721(US20240217978, Example 377 | (S)-(1-(5-amino-2-(fu...)
Affinity DataIC50: 0.100nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683364(US20240217978, Example 11 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 0.100nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683366(US20240217978, Example 13 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 0.100nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683371(US20240217978, Example 18 | (S)-2-((7-amino-)
Affinity DataIC50: 0.125nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683370(US20240217978, Example 17 | (S)-2-((7-amino-)
Affinity DataIC50: 0.135nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683512(US20240217978, Example 167 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 0.200nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683629(US20240217978, Example 285 | (S)-(1-(7-amino-)
Affinity DataIC50: 0.200nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683359(US20240217978, Example 6 | (S)-2-((7-amino-)
Affinity DataIC50: 0.214nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683509(US20240217978, Example 164 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 0.300nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683585(US20240217978, Example 240 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 0.300nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683363(US20240217978, Example 10 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 0.357nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683367(US20240217978, Example 14 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 0.368nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683424(US20240217978, Example 77 | 4-((7-amino-2-(furan-2...)
Affinity DataIC50: 0.400nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683357(US20240217978, Example 4)
Affinity DataIC50: 0.458nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683385(US20240217978, Example 32 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 0.5nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683508(US20240217978, Example 163 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 0.5nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683494(US20240217978, Example 149 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 0.5nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683728(US20240217978, Example 384 | 2-(4-((7-amino-2-(fur...)
Affinity DataIC50: 0.5nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683468(US20240217978, Example 123 | Ethyl 4-(4-((7-amino-...)
Affinity DataIC50: 0.5nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683510(US20240217978, Example 165 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 0.600nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683722(US20240217978, Example 378 | (S)-(1-(5-amino-2-(fu...)
Affinity DataIC50: 0.700nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683640(US20240217978, Example 296 | (S)-(1-(5-amino-2-(fu...)
Affinity DataIC50: 0.800nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683670(US20240217978, Example 326 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 0.800nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683718(US20240217978, Example 374 | ((S)-1-(7-amino-)
Affinity DataIC50: 0.800nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683602(US20240217978, Example 257 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 0.800nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683729(US20240217978, Example 385 | (S)-(5-(7-amino-2-(fu...)
Affinity DataIC50: 0.800nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683606(US20240217978, Example 261 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 0.900nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683605(US20240217978, Example 260 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 0.900nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683720(US20240217978, Example 376 | (S)-(1-(5-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683434(US20240217978, Example 87 | (S)-(1-(7-amino-2-(5-m...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683716(US20240217978, Example 372 | ((S)-1-(7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683555(US20240217978, Example 210 | (S)-(1-(7-amino-2-(5-...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683410(US20240217978, Example 63 | 4-((7-amino-2-)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683601(US20240217978, Example 256 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683384(US20240217978, Example 31 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683383(US20240217978, Example 30 | (S)-2-((7-amino-2-(fur...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683639(US20240217978, Example 295 | (S)-(1-(5-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683545(US20240217978, Example 200 | (S)-(1-(7-amino-2-(5-...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683731(US20240217978, Example 387 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683551(US20240217978, Example 206 | (S)-(1-(7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683679(US20240217978, Example 335 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683554(US20240217978, Example 209 | (S)-(1-(7-amino-2-(5-...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683586(US20240217978, Example 241 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683356(US20240217978, Example 3 | (S)-2-((7-amino-2-(fura...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683355(US20240217978, Example 2)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683419(US20240217978, Example 72 | ((S)-1-(7-amino-)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Chong Kun Dang Pharmaceutical

US Patent
LigandPNGBDBM683515(US20240217978, Example 170 | (S)-2-((7-amino-2-(fu...)
Affinity DataIC50: 1nMAssay Description:A radioligand binding test was conducted by using [3H]-NECA (5′-N-[adenine-2,8-3H]-ethylcarboxamidoadenosine) and an adenosine A2a membrane. As...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 397 total ) | Next | Last >>
Jump to: